Special EQA Program in Accordance with the RKI-Entero Surveillance Program Virus Detection – Enterovirus-PCR/Cultivation and Typing (typing is required)
[Spezial-Ringversuch im Rahmen des RKI-Entero-Surveillance-Programms Virus-Nachweis – Enterovirus-PCR/Anzucht u. Typisierung (Typ. erforderlich)]
EPTIS factsheet 437211 | Last revision 2017-10-26 | URL: https://www.eptis.bam.de/pts437211 https://www.eptis.bam.de/pts437211
PT provider | |||||||
PT provider | INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories | ||||||
Based in | Germany | ||||||
Language(s) | German, English | ||||||
Remarks | Please fill in page 2 of the order form for handling of infectious samples for EQAS unless you already returned your completed form 2 to INSTAND e. V. when you registered for recent EQA schemes. Without your confirmation we cannot send you the EQAS samples. Please note: Specification of an enterovirus type is required in this EQA program. This program does NOT replace the EQA scheme “Virus genome detection – Enteroviruses (372)”! Please note that participation in this special EQA program in accordance with the RKI-Entero Surveillance Program requires virus propagation in cell culture before carrying out virus typing. The INSTAND EQA schemes in virology are carried out in scientific cooperation with the Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten (DVV e.V.), Gesellschaft für Virologie (GfV e.V.) and Deutsche Gesellschaft für Hygiene und Mikrobiologie (DGHM e.V.). The characterization of the EQA samples including the determination of the target values/consensus values is carried out in cooperation with the INSTAND Expert laboratories. Cooperation with: Nationales Referenzzentrum für Poliomyelitis und Enteroviren, Robert Koch-Institut, Berlin Information for 2018 (for details please see www.instand-ev.de -> EQAS and EQAS Online) | ||||||
Keywords | |||||||
Product groups |
Human test material
|
||||||
Testing fields |
Medical analysis
|
||||||
Technical details | |||||||
|
|||||||
Aims of the PT scheme | |||||||
Target group of participants | |||||||
Linked to specific legislation / standards | |||||||
Additional, subsidiary aims | |||||||
Number of participants | < 50 | ||||||
Accredited or otherwise reviewed by a 3rd party |
Accredited by DAkkS (Germany) on the basis of ISO/IEC 17043 |
||||||
Operation is commissioned / requested by | German Bundesärztekammer (General medical Council) | ||||||
Fees and frequency | |||||||
Participation fee | 172 Euro | ||||||
Regularly operated | Yes (Once every two years (2018; 2020)) | ||||||
Year of first operation | Experience with operation of ILCs since 1968 | ||||||
Contact details of the PT provider | |||||||
Provider | Contact person | ||||||
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
P.O.Box 250211, Ubierstrasse 20 40223 Düsseldorf Germany Phone: +49-211-159213-0 Fax: +49-211-159213-30 Web: http://www.instandev.de/ http://www.instandev.de/ |
Dr. rer. nat. Nathalie Wojtalewicz
Phone: +49-211-15921341 Fax: +49-211-15921330 Email: wojtalewicz@instand-ev.de wojtalewicz@instand-ev.de |